A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is a 24-month study to evaluate multiple doses of AGN211745 (previously known as
Sirna-027) in treatment of subfoveal choroidal neovascularization associated with age-related
macular degeneration